1. Avilés, A., Guzmán, R., Delgado, S., Nambo, M.J., García, E.L. and Diaz-Maqueo, J.C. (1996) Intensive brief chemotherapy with hematopoietic growth factors as hemato-logical support and adjuvant radiotherapy improve prognosis in aggressive malignant lymphoma.Am. J. Hematol. 52, 275–80.
2. Roth M.S. and Foon, K.A. (1996) Alpha interferon in the treatment of hematological malignancies.Am. J. Med. 81, 875–82.
3. Leavitt, R.D., Ratanathraton, V., Ozer, H., Utman, J.E., Portclock, C., Myers, J.W., Kisner, D., Norred, S., Spiegel, RJ. and Bonnemm, E.R. (1987) Alfa interferon in the treatment of Hodgkin’s disease and non-Hodgkin’s Lymphoma.Sem. Oncol. 14 (Suppl. 2), 18–23.
4. Gilewski T.A. and Richards, J.M. (1990) Biological response modifiers in non-Hodgkin’s lymphoma.Sem. Oncol. 17, 74–87.
5. Smalley, R.V., Andersen, J.W., Hawkins, M.J., Bhide, V., O’Connell, M.J., Oken, M.M. and Borjen, E.C. (1992) Interferon alfa combined chemotherapy for patients with non-Hodgkin’s lymphoma.N. Eng. J. Med. 327, 1336–41.